Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

Related Articles by Review for PubMed (Select 16186472)

1.

Description of a new hepatitis C risk assessment tool.

Nguyen MT, Herrine SK, Laine CA, Ruth K, Weinberg DS.

Arch Intern Med. 2005 Sep 26;165(17):2013-8.

PMID:
16186472
2.

Screening for hepatitis C virus infection: a review of the evidence for the U.S. Preventive Services Task Force.

Chou R, Clark EC, Helfand M; U.S. Preventive Services Task Force.

Ann Intern Med. 2004 Mar 16;140(6):465-79. Review.

PMID:
15023713
3.

Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis.

Xia X, Luo J, Bai J, Yu R.

Public Health. 2008 Oct;122(10):990-1003. doi: 10.1016/j.puhe.2008.01.014. Epub 2008 May 19. Review.

PMID:
18486955
4.

Health strategy on HCV in The Netherlands.

van Hattum J.

Acta Gastroenterol Belg. 2002 Apr-Jun;65(2):115-7. Review.

PMID:
12148432
5.

Hepatitis C among drug users: consensus guidelines on management in general practice.

Barry J, Bourke M, Buckley M, Coughlan B, Crowley D, Cullen W, Dooley S, Keating S, Kelleher D, Moloney J, Murray F, McCormick PA, MacMathuna P, O'Connor J, O'Grady J, O'Sullivan C, O'Sullivan P, Quinn C, Smyth B, Sweeney B; Dublin Area Hepatitis C Initiative Group.

Ir J Med Sci. 2004 Jul-Sep;173(3):145-50. Review.

PMID:
15693384
6.
7.

Screening in liver disease.

Del Poggio P, Mazzoleni M.

World J Gastroenterol. 2006 Sep 7;12(33):5272-80. Review.

8.

[How to improve the efficacy of hepatitis C screening campaigns?].

Monnet E, Miguet JP.

Gastroenterol Clin Biol. 2004 Aug-Sep;28(8-9):711-3. Review. French. No abstract available.

PMID:
15646537
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk